​Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Publication: Arthritis Care and Research
UBC Author(s): Mark Harrison (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 2151464X
Volume: 78
Page Range: 296-302
Publication Date: February 2026